5092 Effect of Fezolinetant Treatment on Patient-Reported Outcomes: Data from Phase 3b study (DAYLIGHT) for Moderate-To-Severe Vasomotor Symptoms Associated with Menopause in Women Considered Unsuitable for Hormone Therapy
5092 菲唑利坦治疗对患者报告结局的影响：来自针对不适合接受激素治疗的中重度更年期相关血管舒缩症状女性的3b期研究（DAYLIGHT）的数据
期刊:GMS German Medical Science
影响因子:
doi:10.1210/jendso/bvae163.1587
Möckel, Frank; Hoffmann, Gerd; Obermüller, Roy; Drobnik, Wolfgang; Schmitz, Gerd; Shapiro C.M., Marla; Wu, Xi; Wang, Xuegong; Miyazaki, Kentaro; Morga, Antonia; Nappi, Rosella E; Stute, Petra; Martins, Karla; Schaudig, Katrin
